More targets, more pathways and more clues for mutant p53

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Mutations in the p53 transcription factor are frequent in human cancers, often leading to aggressive disease.
• Understanding how mutant p53 affects gene expression is crucial for identifying therapeutic targets.

Purpose of the Study:

• To review literature on mutant p53-driven transcriptome changes.
• To determine if p53 mutations have mutation-specific effects on gene reprogramming.
• To identify mechanisms, novel target genes, and affected cellular pathways.

Main Methods:

• Literature review focusing on mutant p53-dependent transcriptome changes.
• Analysis of gene expression data, promoter regions, and ChIP-seq data.
• Pathway enrichment analysis.

Main Results:

• Nearly 600 genes showed consistent up/downregulation with mutant p53 expression, irrespective of the specific mutation.
• Expression changes are largely due to the loss of both wild-type p53's activation and repressor functions.
• Affected pathways include amino acid metabolism (aspartate, glutamate, arginine, proline).

Conclusions:

• Transcriptional reprogramming by mutant p53 is largely mutation-independent.
• Loss of wild-type p53 functions explains most observed gene expression changes.
• Novel candidate target genes involved in metabolism, xenobiotic responses, and cell differentiation were identified.